Table 1.
Clinical and laboratory profiles of 47 patients with systemic sclerosis.*
| Age (years) | 44·0 ± 1·7 |
| Sex (M/F) | 2/45 |
| Disease duration (months) | 62·6 ± 6·1 |
| Type of SSc (diffuse/limited) | 20/27 |
| Raynaud's phenomenon | 45/47 (95·7%) |
| Modified Rodnan score | 11·5 ± 1·5 |
| Oesophageal involvement | 23/47 (48·9%) |
| Interstitial lung disease | 27/47 (57·4%) |
| Pulmonary artery hypertension | 3/47 (6·4%) |
| Arthritis | 11/47 (23·4%) |
| Digital ulcer | 20/47 (42·6%) |
| Antibodies to Scl70 | 26/47 (55·3%) |
| Antibodies to centromere | 4/47 (8·5%) |
Data are expressed as percentage (parenthesis) or mean ± standard error of the mean.